Sign in
4

Changes in Ownership

Phreesia, Inc. Filed Acc 0001127602-25-012493

SVP, Life Sciences sold 260 shares at $23.04 ($5,991)

From the SEC's structured data for this filing

Trades in this filing

Linetsky David · SVP, Life Sciences

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-04-21 Sale : show line 1 in the form −260 $23.04 $5,991 8,752 I
Open-market sales · 260 sh · avg $23.04 · $5,991
Loading xslF345X05/form4.xml…